EBR · ASX

EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (ASX:EBR)

AU$1.75

 -0.04 (-2.235%)
ASX:Live
31/03/2025 04:10:58 PM
Recent Price upgrade Hammer Bullish HALO Ords HALO Momentum HALO Earnings Momentum +3
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

EBR Overview

EBR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Neutral

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

About EBR

Website

N/A

Telephone

1.408.720.1906

Address

480 Oakmead Parkway Sunnyvale, CA 94085

Description

EBR Systems, Inc. engages in the development of implantable systems for wireless tissue stimulation. Its WiCS Wireless Cardiac Stimulation technology helps address the significant opportunity to eliminate cardiac pacing leads. The company was founded by Richard E. Riley and Debra Sheryl Echt in 2003 and is headquartered in Sunnyvale, CA.

EBR Price Chart

Key Stats

Market Cap

AU$689.77M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.8 - 2.08

Trade Value (12mth)

US$75,117.00

1 week

-9.14%

1 month

16.23%

YTD

62.73%

1 year

125.46%

All time high

2.08

Key Fundamentals

EPS 3 yr Growth

-86.70%

EBITDA Margin

N/A

Operating Cashflow

-$41m

Free Cash Flow Return

-59.10%

ROIC

-58.50%

Interest Coverage

-6.30

Quick Ratio

7.60

Other Data

Shares on Issue (Fully Dilluted)

371m

HALO Sector

Healthcare

Next Company Report Date

23-Mar-26

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

EBR Announcements

Latest Announcements

Date Announcements

25 March 25

Appendix 4E SEC Form 10K

×

Appendix 4E SEC Form 10K

25 March 25

2024 Activity Report and Form 10-K submission

×

2024 Activity Report and Form 10-K submission

25 March 25

Investor Presentation

×

Investor Presentation

25 March 25

Quarterly Cash Flow Report

×

Quarterly Cash Flow Report

21 March 25

Amendment to Bylaws of EBR Systems, Inc.

×

Amendment to Bylaws of EBR Systems, Inc.

10 March 25

Notification regarding unquoted securities - EBR

×

Notification regarding unquoted securities - EBR

07 March 25

Notification of cessation of securities - EBR

×

Notification of cessation of securities - EBR

05 March 25

Application for quotation of securities - EBR

×

Application for quotation of securities - EBR

27 February 25

Update on Timing of Annual Meeting of Stockholders

×

Update on Timing of Annual Meeting of Stockholders

25 February 25

Notice of Date for Form 10-K

×

Notice of Date for Form 10-K

20 February 25

Notification regarding unquoted securities - EBR

×

Notification regarding unquoted securities - EBR

19 February 25

Annual Meeting of Stockholders

×

Annual Meeting of Stockholders

18 February 25

Notification of cessation of securities - EBR

×

Notification of cessation of securities - EBR

17 February 25

Application for quotation of securities - EBR

×

Application for quotation of securities - EBR

28 January 25

EBR leases new facility to expand manufacturing capabilities

×

EBR leases new facility to expand manufacturing capabilities

21 January 25

CEO Investor Presentation

×

CEO Investor Presentation

20 January 25

EBR completes FDA PAI and update on FDA approval timing

×

EBR completes FDA PAI and update on FDA approval timing

20 January 25

WiSE accepted into new TCET reimbursement pathway of CMS

×

WiSE accepted into new TCET reimbursement pathway of CMS

08 January 25

Notification of cessation of securities - EBR

×

Notification of cessation of securities - EBR

07 January 25

Notification regarding unquoted securities - EBR

×

Notification regarding unquoted securities - EBR

06 January 25

Response to ASX Price Query

×

Response to ASX Price Query

06 January 25

FDA Pre-Approval Inspection Update

×

FDA Pre-Approval Inspection Update

03 January 25

Appendix 3Y

×

Appendix 3Y

03 January 25

Application for quotation of securities - EBR

×

Application for quotation of securities - EBR

27 December 24

EBR Systems Investor Roadshow

×

EBR Systems Investor Roadshow

EBR Fundamentals

Per Share Records

Historical data

Forecast data

USD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.12 -0.12 -0.13 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.12 -0.12 -0.13 Lock Lock Lock
     Growth % Lock Lock Lock Lock 87.1 1.2 -4.3 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.12 -0.11 -0.11 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.11 -0.11 -0.13 Lock Lock Lock
     Growth % Lock Lock Lock Lock -33.1 6.5 2.4 Lock Lock Lock
     Yield % Lock Lock Lock Lock -36.2 -28.3 -18.9 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.16 0.10 0.07 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.16 0.10 0.07 Lock Lock Lock
     Growth % Lock Lock Lock Lock -43.1 -37.7 -34.6 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 272 291 325 Lock Lock Lock
Basic m Lock Lock Lock Lock 272 291 325 Lock Lock Lock

Financial Records

Historical data

Forecast data

USD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 33 34 38 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -1 -1 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -69.9 -15.3 21.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -33 -34 -38 Lock Lock Lock
     Growth % Lock Lock Lock Lock -46.8 -2.8 -11.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -34 -35 -38 Lock Lock Lock
     Growth % Lock Lock Lock Lock -47.2 -3.1 -10.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -33 -35 -41 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -33 -35 -41 Lock Lock Lock
     Growth % Lock Lock Lock Lock 16.9 -5.9 -16.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -30 -33 -41 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 1 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -49 -9 1 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 17 40 32 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -31 -33 -42 Lock Lock Lock
     Growth % Lock Lock Lock Lock -34.8 -6.3 -25.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 64 72 61 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 72 79 74 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 21 41 41 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -42 -31 -19 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 28 48 49 Lock Lock Lock
Equity $m Lock Lock Lock Lock 45 30 26 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 65 72 65 Lock Lock Lock
     Growth % Lock Lock Lock Lock -16.4 10.9 -9.9 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -46.2 -44.4 -55.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -73.6 -116.0 -157.2 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -46.6 -51.3 -54.6 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -46.9 -52.2 -58.5 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -43.0 -48.7 -59.1 Lock Lock Lock

Ratios Records

Historical data

Forecast data

USD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -21.5 -7.5 -6.3 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.3 0.9 0.5 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -93.4 -101.7 -74.3 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 11.2 11.5 7.7 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 11.2 11.5 7.6 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 95.4 97.2 94.1 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -511.9 -507.1 -495.1 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.0 0.0 0.8 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -46.2 -44.4 -55.5 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.6 2.6 2.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -73.6 -116.0 -157.2 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -73.6 -116.0 -157.2 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 0.0 0.0 460.3 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 0.0 0.0 460.3 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 1,054.6 934.9 463.3 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -1,054.6 -934.9 -3.0 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

EBR Shortsell

Frequently Asked Questions

The current share price of EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX) is AU$1.75.
The 52-week high share price for EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX) is AU$2.08.
The 52-week low share price for EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX)? is AU$0.80.
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX) does not pay a dividend.
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX) does not pay a dividend.
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX) has a franking level of 0.0%.
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX) is classified in the Healthcare.
The current P/E ratio for EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.